Endo International plc (NASDAQ:ENDP) (TSE:ENL) has been given an average rating of “Hold” by the nine ratings firms that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $7.36.
ENDP has been the subject of several research analyst reports. Piper Sandler downgraded Endo International from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $10.00 to $3.00 in a research note on Tuesday, August 31st. Royal Bank of Canada reduced their target price on Endo International from $6.00 to $5.00 and set a “sector perform” rating for the company in a research note on Monday, August 9th.
Shares of NASDAQ:ENDP opened at $4.12 on Monday. Endo International has a 12-month low of $1.94 and a 12-month high of $10.89. The company has a market capitalization of $962.02 million, a PE ratio of 14.71 and a beta of 1.37. The business has a 50 day moving average of $3.16 and a two-hundred day moving average of $4.63.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Russell Investments Group Ltd. boosted its stake in shares of Endo International by 63.0% in the second quarter. Russell Investments Group Ltd. now owns 418,260 shares of the company’s stock valued at $1,957,000 after purchasing an additional 161,675 shares during the period. Geode Capital Management LLC raised its holdings in Endo International by 15.5% in the first quarter. Geode Capital Management LLC now owns 4,105,987 shares of the company’s stock valued at $30,425,000 after acquiring an additional 549,953 shares in the last quarter. Tudor Investment Corp Et Al acquired a new stake in Endo International in the first quarter valued at approximately $941,000. LSV Asset Management raised its holdings in Endo International by 1,928.1% in the second quarter. LSV Asset Management now owns 452,259 shares of the company’s stock valued at $2,116,000 after acquiring an additional 429,959 shares in the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp raised its holdings in Endo International by 19.0% in the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 245,380 shares of the company’s stock valued at $1,762,000 after acquiring an additional 39,180 shares in the last quarter. 79.73% of the stock is owned by institutional investors and hedge funds.
About Endo International
Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals.
Recommended Story: Understanding debt-to-equity ratio in fundamental analysis
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.